128 related articles for article (PubMed ID: 10368188)
1. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
Murakami Y; Kanda K; Tsuji M; Kanayama H; Kagawa S
BJU Int; 1999 May; 83(7):743-7. PubMed ID: 10368188
[TBL] [Abstract][Full Text] [Related]
2. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.
McKiernan JM; Buttyan R; Bander NH; de la Taille A; Stifelman MD; Emanuel ER; Bagiella E; Rubin MA; Katz AE; Olsson CA; Sawczuk IS
Cancer; 1999 Aug; 86(3):492-7. PubMed ID: 10430258
[TBL] [Abstract][Full Text] [Related]
3. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
[TBL] [Abstract][Full Text] [Related]
5. [MN/CA IX antigen as a potential target for renal cell carcinoma].
Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
[TBL] [Abstract][Full Text] [Related]
6. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
7. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
[TBL] [Abstract][Full Text] [Related]
9. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E
Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
[TBL] [Abstract][Full Text] [Related]
10. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
Jiang YD; Ren F; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
[TBL] [Abstract][Full Text] [Related]
11. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
Raina P; Singh SK; Goswami AK; Kashyap MK; Khullar M; Sharma SK; Barwal KC
Mol Cell Biochem; 2022 Feb; 477(2):333-343. PubMed ID: 34716861
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
13. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
Uemura H
Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
[TBL] [Abstract][Full Text] [Related]
14. Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.
de la Taille A; Katz A; Cao Y; McKiernan J; Buttyan R; Burchardt M; Burchardt T; Hayek O; Olsson CA; Chopin DK; Sawczuk IS
Urology; 2000 Sep; 56(3):393-8. PubMed ID: 10962301
[TBL] [Abstract][Full Text] [Related]
15. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
[TBL] [Abstract][Full Text] [Related]
16. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
Tostain J; Li G; Gentil-Perret A; Gigante M
Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
[TBL] [Abstract][Full Text] [Related]
18. CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma.
Li G; Feng G; Zhao A; Péoc'h M; Cottier M; Mottet N
Biomarkers; 2017 Mar; 22(2):123-126. PubMed ID: 27775441
[TBL] [Abstract][Full Text] [Related]
19. CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
Clin Exp Metastasis; 2007; 24(3):149-55. PubMed ID: 17390110
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
Gigante M; Li G; Ferlay C; Perol D; Blanc E; Paul S; Zhao A; Tostain J; Escudier B; Negrier S; Genin C
Anticancer Res; 2012 Dec; 32(12):5447-51. PubMed ID: 23225450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
